Immunol Cell Biol (2008) 86(8):6508
Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 ReceptorDependent and Independent Pathways
In stark contrast, dietary supplements marketed as "GLP-1" products are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which places the burden of safety on manufacturers rather than requiring pre-market approval
In a 2025 review, the authors describe this species as occupying an extraordinary niche in the human gut, and a model organism studied for its ability to modulate human health and gut microbiome structure.13 In animal studies, it has slowed the development and progression of diabetes , obesity , and irritable bowel disease .14 In human trials, it has helped participants reduce their BMI and improve their diabetic markers.12 Its effects on obesity and diabetes have been recreated in humans as well
Many private insurers will approve these drugs when prescribed for diabetes management but exclude them when used primarily for weight loss
4,5 TABLE 1 provides a summary of key characteristics of currently available injectable GLP-1 receptor agonists
